Looks like you’re on the UK site. Choose another location to see content specific to your location
Galderma completes acquisition of Inneov nutraceutical assets
Galderma has completed its acquisition of certain assets from Inneov Group, as originally announced in April 2015.
As a result of the successful conclusion of the regulatory process and customary closing conditions, the firm has gained ownership of a number of Inneov brands, such as Nutri-Care D, Duocap, Densilogy, Densilogy Men, Fermete, Fermete Aox, Firmness, Pre-Hyaluron 465, Solar and Sun Sensitivity.
This purchase will serve as the foundation for Galderma's planned entry into the nutraceutical market, which is expected to align with its current business activities in the field of self-medication.
Inneov's portfolio is supported by science and clinical evidence, with the various offerings recommended by healthcare professionals for aiding the healthy upkeep of the skin, hair and nails.
Stuart Raetzman, chief executive officer of Galderma, said: "We look forward to expanding our range of nutraceutical products and to serving consumers' needs around the world."
Formerly a joint venture between L'Oreal and Nestle, Galderma was bought out completely by Nestle last year.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard